The 15-LO-1/15-HETE system promotes angiogenesis by upregulating VEGF in ischemic brains

Neurol Res. 2017 Sep;39(9):795-802. doi: 10.1080/01616412.2017.1321710. Epub 2017 May 1.

Abstract

Objectives: Angiogenesis promotes neurobehavioral recovery after cerebral ischemic stroke. 15(S)-hydroxyeicosatetraenoic acid (15-HETE) is one of the major metabolites of arachidonic acid by 15-lipoxygenase (15-LO) and stimulates the production of vascular endothelial growth factor (VEGF), thus, inducing autocrine-mediated angiogenesis. The present study aimed to investigate the role of 15-LO/15-HETE system on VEGF expression and angiogenesis in brain ischemia.

Methods: Rat cerebral arterial vascular endothelial cells were used to set up a cell injury model of oxygen-glucose deprivation and reoxygenation (OGD/R), mimicking a condition of brain ischemia. A mouse model of middle cerebral artery occlusion (MCAO) was established.

Results: Oxygen-glucose deprivation increased cellular expression of 15-LO-1 and VEGF. Transfection of 15-LO-1 siRNA depleted cells of 15-LO-1, and sequentially induced downregulation of VEGF expression; while, incubation of 15-HETE increased the expression of VEGF. Incubation of 15-HETE attenuated the reduction in cell viability induced by oxygen-glucose deprivation, and promoted cell migration, while transfection of 15-LO-1 siRNA showed an opposite effect. In animal experiments, the density of microvessels in hypoxic regions of brains was significantly increased after MCAO, while intracerebroventricular delivery of 15-LO-1 siRNA significantly reduced the density of microvessels, and downregulates VEGF expression.

Discussion: The results indicate that the 15-LO-1/15-HETE system promotes angiogenesis in ischemic brains by upregulation of VEGF, representing a potential target for improving neurobehavioral recovery after cerebral ischemic stroke.

Keywords: 15(S)-hydroxyeicosatetraenoic acid; 15-lipoxygenase; Ischemic stroke; vascular endothelial growth factor.

MeSH terms

  • Angiogenesis Inducing Agents / therapeutic use
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology
  • Cell Movement
  • Cells, Cultured
  • Cerebral Arteries / cytology
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Glucose / deficiency
  • Hydroxyeicosatetraenoic Acids / genetics
  • Hydroxyeicosatetraenoic Acids / metabolism*
  • Hydroxyeicosatetraenoic Acids / therapeutic use
  • Hypoxia / drug therapy
  • Hypoxia / metabolism
  • Mice
  • Platelet Endothelial Cell Adhesion Molecule-1 / metabolism
  • RNA, Small Interfering / therapeutic use
  • Rats
  • Signal Transduction
  • Time Factors
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Angiogenesis Inducing Agents
  • Hydroxyeicosatetraenoic Acids
  • Platelet Endothelial Cell Adhesion Molecule-1
  • RNA, Small Interfering
  • Vascular Endothelial Growth Factor A
  • 15-hydroxy-5,8,11,13-eicosatetraenoic acid
  • Glucose